The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
Talc is a natural mineral widely used in cosmetics and personal care products for purposes such as moisture absorption, preventing clumping, providing opacity to cosmetics, and improving product texture. However, since talc and asbestos can coexist in the same rock types and may contaminate each other during mining, testing for asbestos in cosmetics is crucial.
The FDA has long been sampling and testing talc-containing cosmetics for asbestos and collaborating with federal partners to reduce consumer exposure to asbestos risks. After considering scientific evidence and complex policy issues related to testing and identifying talc and asbestos in talc-containing cosmetics, the FDA believes the proposed testing techniques are appropriate for detecting asbestos and will help ensure the safety of talc-containing cosmetics. FDA proposed requiring manufacturers to use methods such as polarized light microscopy (PLM) and transmission electron microscopy/energy dispersive X-ray spectroscopy/selective area electron diffraction (TEM/EDS/SAED) for asbestos testing.
The proposed rule mandates manufacturers to test representative samples from each batch of talc-containing cosmetics or representative samples from each batch of talc ingredients used in cosmetics.
Moreover, if manufacturers can establish and maintain the reliability of supplier analytical certificates through validation testing and determine the qualifications of suppliers, they may rely on the supplier’s analytical certificate for talc. If manufacturers fail to comply with the testing or record-keeping requirements in the rule, their talc-containing cosmetics will be considered adulterated under Section 601(c) of the Federal Food, Drug, and Cosmetic Act.
Additionally, if the cosmetics contain asbestos, or if the talc used in cosmetics contains asbestos, the cosmetics will be deemed adulterated under Section 601(a) of the Federal Food, Drug, and Cosmetic Act. Similarly, if the talc used in cosmetics contains asbestos, that talc will also be considered adulterated under Section 601(a) of the Federal Food, Drug, and Cosmetic Act.
The implementation of the proposed rule will help protect consumers to some extent and reduce the chances of asbestos exposure, thereby lowering the risk of asbestos-related diseases.
Reference:
FDA: Talc Cosmetics Will Mandate Asbestos Testing
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
L-Phenylalanine (L-Phe) is an essential and proteinogenic amino acid that helps build proteins and produces brain chemicals like dopamine and norepinephrine. L-Phenylalanine is one of the 20 standard amino acids that form long chains called polypeptides (proteins).The body cannot produce it, so it must be obtained through diet or supplements.
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.